Analytical method

An analytical method is a defined laboratory procedure for identifying a compound in a sample, measuring its concentration, or both. It is not a study design itself — it is the measurement layer underneath nearly every pharmacological claim. When a paper reports a blood concentration, a detection threshold, or a metabolite ratio, an analytical method produced that number.

The most common types in pharmacology and toxicology are chromatographic methods — high-performance liquid chromatography (HPLC) and gas chromatography (GC) — typically paired with a mass spectrometer (MS). The spectrometer confirms identity by molecular weight and fragmentation pattern, distinguishing compounds that would otherwise be confused. Immunoassays, used in point-of-care drug testing, offer speed at the cost of specificity.

Each method is developed and validated for a specific sample type — blood, urine, hair, oral fluid — and each carries defined limits of detection and quantification. These limits are part of what a method reports about itself; a validated method documents exactly the conditions under which its results hold.

What this design can establish

A validated analytical method can establish that a specific compound is present in a sample and, within its stated limits, at what concentration. When paired with mass spectrometry, it can resolve structurally similar compounds — isomers, metabolites, analogues — that less specific methods treat as identical. This matters for pharmacokinetic studies, toxicological reporting, and the identification of adulterants.

The method also characterises its own uncertainty. Detection limits, quantification thresholds, matrix effects, and analytical recovery are all part of a formal validation record. A well-reported method tells a reader exactly how far its measurement reaches into a sample, and where its confidence ends.

What it cannot

An analytical method establishes what is in a sample; it says nothing about effect, impairment, or harm. The most common misreading is treating a positive detection as evidence of pharmacological activity at the time of sampling — a metabolite found in urine days after exposure carries no information about the experience that produced it.

Methods also do not transfer between sample types without re-validation. A procedure developed for blood may perform poorly on oral fluid or hair, which have different chemical compositions and binding properties. An absent result from an unvalidated matrix is not evidence of absence — it may simply reflect the wrong tool for the sample type.

A further limit is invisible in many published papers: studies often report concentrations without disclosing the analytical method used, its limits of detection, or whether formal validation was performed. In that case the number stands without the context needed to evaluate it — an absent method record is a stated gap, not a hidden one.